Is it worth quitting smoking later in life?

Yes. Quitting reduces risk at any age, and long-term cohort evidence shows that stopping — especially before middle age — avoids most of the excess mortality associated with continued smoking.

Why combine counselling with medication for quitting?

Behavioural support helps people change the habit and manage triggers, while medication reduces craving and withdrawal from nicotine dependence. Evidence shows that combining the two raises the chance of sustained quitting compared with either alone.

Smoking Cessation

Smoking cessation is the process of stopping tobacco use, and supporting it is one of the highest-value preventive activities in primary care because quitting substantially lowers the risk of cardiovascular disease, cancer, and lung disease at any age. Effective cessation combines behavioural support with pharmacotherapy to overcome nicotine dependence.

Definition

Smoking cessation is the discontinuation of tobacco smoking, typically supported by behavioural interventions and pharmacotherapy that address both the behavioural habit and the physiological dependence on nicotine.

Scope

The topic covers why tobacco use is harmful, the nature of nicotine dependence, and the evidence-based components of cessation support — brief advice, behavioural counselling, and pharmacological aids such as nicotine replacement. It is presented as reference and educational material on how cessation is supported and why it works, not as individualised treatment or dosing guidance.

Core questions

How much and how quickly does stopping smoking reduce health risk?
Which combinations of behavioural and pharmacological support most improve the chance of sustained quitting?
How can cessation support be delivered routinely and briefly within primary-care encounters?

Key concepts

Nicotine dependence
Brief advice and the quit attempt
Behavioural counselling
Nicotine replacement therapy
Non-nicotine pharmacotherapy
Relapse and sustained abstinence
Combination of behavioural and pharmacological support
Reversibility of risk after quitting

Mechanisms

Tobacco smoke delivers nicotine, which acts on brain reward pathways to produce dependence, alongside numerous toxic and carcinogenic combustion products that damage the cardiovascular and respiratory systems and initiate carcinogenesis. Cessation interventions work on two fronts: behavioural support helps people plan and sustain a quit attempt and manage triggers, while pharmacotherapy reduces craving and withdrawal — nicotine replacement therapy supplies nicotine without the harmful combustion products, and other medicines act on nicotinic or other pathways. Combining behavioural and pharmacological support raises quit rates more than either alone. Because much of smoking's harm comes from continued exposure, stopping reduces excess risk progressively, and stopping earlier in life avoids most of the excess mortality.

Clinical relevance

Asking about tobacco use and offering cessation support is a routine, high-impact preventive task in family medicine, and brief advice plus an offer of treatment is recommended at the population level. This entry summarises the evidence base and mechanisms for educational reference; it does not provide individualised treatment selection or dosing, which depend on the person's circumstances, preferences, and current guidelines.

Epidemiology

Tobacco use is one of the leading global causes of preventable death, contributing to cardiovascular disease, many cancers, and chronic respiratory disease. Long-term cohort evidence shows that lifelong smoking markedly shortens life expectancy, while quitting — especially before middle age — avoids most of the excess risk, which is why cessation is a central preventive priority.

Evidence & guidelines

The US Preventive Services Task Force recommends that clinicians ask all adults about tobacco use and offer behavioural interventions and, for non-pregnant adults, pharmacotherapy for cessation. Cochrane systematic reviews provide the supporting evidence, including for nicotine replacement therapy versus control. Specific drug choices and regimens are covered by current guidelines and are outside the scope of this reference entry.

History

The health harms of smoking were established by mid-twentieth-century epidemiology, notably Doll and Hill's work and the decades-long British Doctors Study, which quantified smoking's effect on mortality and the benefit of quitting. As the causal evidence solidified, attention turned to helping people stop, and cessation support evolved from simple advice to structured behavioural counselling combined with pharmacotherapy supported by randomised trials.

Key figures

Richard Doll
Richard Peto

Seminal works

doll-2004
jha-2014
uspstf-tobacco-2021

Frequently asked questions

Is it worth quitting smoking later in life?: Yes. Quitting reduces risk at any age, and long-term cohort evidence shows that stopping — especially before middle age — avoids most of the excess mortality associated with continued smoking.
Why combine counselling with medication for quitting?: Behavioural support helps people change the habit and manage triggers, while medication reduces craving and withdrawal from nicotine dependence. Evidence shows that combining the two raises the chance of sustained quitting compared with either alone.